About Us

Who We Are

Partnering with leading pharmaceutical companies, advanced therapy organizations, universities, hospitals, and government agencies, our team of experts drives innovation in technical operations and manufacturing to support the advancement of groundbreaking therapies for patients in need.

FOOTPRINT, TEAM & CULTURE

A Global Network for Global Impact

Our corporate headquarters is located in Shelton, CT. We provide regional support across the United States and are currently supporting projects globally in the EU and APAC.

Our Team

At Project Farma, we invest in full-time employees, not temporary staff or 1099 contractors. This strategy has built a dedicated and skilled team that forms the backbone of our organization. We take pride in our exceptionally low employee turnover rate.

Our Culture

We foster a collaborative environment that encourages teamwork, creativity, and shared success among our team and clients. This approach allows us to overcome challenges and deliver exceptional results. Our team is known for its supportive, inclusive atmosphere that values people and maintains a patient-centered mindset.

Patient-Focused Project Delivery

Our name, Project Farma (PF), reminds us that the Patient comes First. By focusing on philanthropy and keeping patients at the heart of everything we do, we create a culture driven to provide solutions, meet deadlines, and deliver meaningful outcomes.

Philanthropy

Philanthropy is Built
into our Foundation

As a patient-focused delivery team, we are committed to connecting our team members to patients and their families. Connecting our team to the patients has fostered a culture within our organization that is focused on providing solutions, meeting deadlines and getting results.

Learn More

PF Team

Leadership Team

Anshul Mangal

PF Founder & President of OneSource Life Sciences

Anshul Mangal

PF Founder & President of OneSource Life Sciences

Anshul Mangal is the Founder of Project Farma and President of OneSource Life Sciences at PerkinElmer, where he leads strategy, growth, and execution across advanced manufacturing and biopharmaceutical consulting services. He founded Project Farma to address the life sciences industry’s most complex challenges in regulated manufacturing, capital delivery, and operational readiness, with a focus on enabling rapid, compliant commercialization of novel therapies.

With more than two decades of experience across biotechnology, pharmaceuticals, and life sciences infrastructure, Anshul has led the execution of more than 400 capital projects and over 100 facility builds, representing more than $6B in capital investment. His work spans cell and gene therapy, biologics, and advanced modalities, supporting more than 100 life sciences companies from early development through commercial-scale manufacturing.

Under Anshul’s leadership, Project Farma has grown into a global organization of 200+ professionals and is now a core part of PerkinElmer’s OneSource Life Sciences platform. He serves on the boards of the Alliance for Regenerative Medicines, the Alliance for mRNA Medicines, and IQHQ. Earlier in his career, Anshul practiced as a patent litigator and holds degrees in engineering and law.

Rich Tree

President

Rich Tree

President

Rich Tree serves as President of Project Farma, where he oversees the delivery, operational performance, and strategic initiatives supporting growth across the biopharmaceutical and advanced manufacturing industry. In this role, Rich is responsible for aligning regional and practice-area teams to ensure consistent execution, client satisfaction, and scalable delivery across Project Farma’s portfolio.

Rich brings deep experience across life sciences operations, engineering, and regulated manufacturing environments, with a career spanning pharmaceuticals, biologics, and advanced therapies. He has led global teams through complex capital programs, operational transformations, and high-impact delivery initiatives, with a strong focus on building high-performing organizations and solving complex operational challenges.

Rich is a veteran of the US Navy, and holds a Doctorate Degree in Engineering Management, an MBA, a B.S. in Computer Information Systems, and executive certifications from Stanford University and Harvard Business School. He also brings deep expertise in Lean Six Sigma, organizational design, and business strategy.

Adam Pfeiffer

SVP, Commercial Excellence

Adam Pfeiffer

SVP, Commercial Excellence

Adam Pfeiffer serves as Senior Vice President of Commercial Excellence at Project Farma, where he leads firm-wide business strategy and collaborates closely with operations, marketing, and business development teams to expand Project Farma’s global partnerships across the biopharmaceutical sector.

With more than 20 years of life sciences consulting experience, Adam has supported numerous drug manufacturers in bringing life-saving therapies to market. He brings deep expertise in engineering, commissioning and qualification, and GMP compliance, with a focus on advanced therapies and large-molecule biologics. His experience spans both clinical and commercial manufacturing environments, where he has played a critical role in delivering complex capital projects that enable the development and delivery of cutting-edge treatments.

Adam holds a degree in Chemical Engineering from Colorado State University and is recognized for his ability to bridge technical execution and commercial strategy, aligning Project Farma’s delivery capabilities with evolving client and market needs.

Anthony Wickline

VP, Finance

Anthony Wickline

VP, Finance

Anthony Wickline serves as Vice President of Finance at Project Farma, where he leads financial planning, analysis, and business intelligence to support strategic growth and operational decision-making across the organization. In this role, Anthony partners with leadership and project teams to translate financial data into actionable insights that optimize resources and advance delivery for clients in highly regulated life sciences environments.

Anthony is a Certified Public Accountant (CPA) and brings a strong foundation in accounting and business management, holding a Bachelor of Science in Accounting and Business Management from George Mason University.

Greg Gara

Chief Technology Officer

Greg Gara

Chief Technology Officer

Greg Gara serves as Chief Technology Officer at Project Farma, where he leads technical strategy across advanced manufacturing and supports clients through the full lifecycle of facility development, from design and construction through startup and regulatory licensure.

With more than 30 years of global biotechnology experience, Greg specializes in gene therapy and advanced manufacturing operations, bringing deep expertise in translating complex technical requirements into practical execution across regulated environments. His leadership experience spans TechOps/CMC functions, including manufacturing, engineering, quality, and program management, at both site and global levels.

Greg holds a degree in Biology and Environmental Science from Augusta College and continues to contribute to the advanced therapies space through operational and technical leadership.

Jim Watson

Chief Solutions Officer

Jim Watson

Chief Solutions Officer

Jim Watson serves as Chief Solutions Officer at Project Farma, where he leads capital project leadership, operational readiness, and the delivery of GMP-compliant facilities for advanced therapies, biologics, and large-molecule manufacturing. In this role, Jim partners across technical, engineering, and regulatory stakeholders to define and execute strategic solutions that support client readiness and long-term manufacturing success.

With more than 25 years of experience in the pharmaceutical and biotechnology industries, Jim has led initiatives across the full project lifecycle—including early-phase manufacturing strategy, conceptual and detailed design, facility buildout, commissioning, qualification, validation, and facility turnover. His expertise spans high-purity utility systems, complex infrastructure, and cross-functional program leadership, guiding clients through technical and regulatory complexities to bring novel therapies to market.

Jim holds a Bachelor of Science in Chemical Engineering with Biomedical Interests from Worcester Polytechnic Institute and is currently completing his MBA through the University of Central Oklahoma, reflecting his commitment to both technical depth and strategic leadership.

Joseph Neroni

Regional VP, Central

Joseph Neroni

Regional VP, Central

Joe Neroni serves as Regional Vice President for the Central region at Project Farma, where he leads cross-functional delivery teams supporting biologics, advanced therapies, medical device, and aerospace programs. In this role, Joe is responsible for execution oversight, client partnership, and delivery performance across complex, regulated environments.

Joe brings more than a decade of experience leading and supporting large-scale capital programs exceeding $230MM, with expertise spanning program and project management, turnkey facility builds, automation, validation, and engineering. His experience covers the full project lifecycle from conceptual design and implementation through commissioning and qualification across upstream, downstream, and fill-finish manufacturing processes.

Throughout his career, Joe has worked with early-stage startups, CMOs, CROs, and commercial manufacturers, serving in roles including Project Manager, Engineering Technical Lead, and CQV Lead. He has also provided strategic advisement in technical operations, facility remediation, and business strategy, and has supported the buildout of gene therapy facilities for some of the first-ever commercially approved therapies.

Josh Hoops

Regional VP, Southeast

Josh Hoops

Regional VP, Southeast

Josh Hoops serves as Regional Vice President for the Southeast region at Project Farma, where he leads delivery and growth initiatives across mission-critical industries, including life sciences, data centers, and advanced manufacturing. In this role, Josh is responsible for overseeing execution, building high-performing teams, and driving operational excellence across complex, regulated programs.

Josh brings more than 37 years of leadership experience across commissioning, consulting, and operations, delivering complex capital projects from greenfield construction through operational readiness. His background includes P&L ownership, strategic growth, and organizational transformation, with a proven track record of scaling service lines and building cultures of accountability and execution excellence.

A former U.S. Navy submarine officer, he brings operational precision, leadership under pressure, and a commitment to execution in regulated, high-stakes environments. Prior to joining Project Farma, Josh led a global division at CAI, quadrupling revenue and expanding delivery into new markets. He is known for aligning strategy to execution, developing strong client partnerships, and inspiring teams to deliver outstanding results.

Phil Massey

Regional VP, Northeast

Phil Massey

Regional VP, Northeast

Phil Massey serves as Regional Vice President for the Northeast region at Project Farma, overseeing client portfolios focused on biologics, blood therapies, and next-generation medicines, including cell and gene therapies. In this role, Phil leads delivery teams and chairs technical task forces that shape compliant strategies spanning pre-clinical development through commercial manufacturing.

Phil began his career in Australia at Pfizer before transitioning into consulting, where he has guided cross-functional teams across project management, facilities and infrastructure, process equipment, manufacturing operations, and quality initiatives. His experience spans highly regulated environments and complex technical programs supporting both early-stage and commercial manufacturing.

More recently, Phil’s work with Project Farma has included building technical operations programs for some of the first-ever commercially approved gene therapies in the United States and the United Kingdom. He holds a degree in Economics and Communications from Macquarie University in Sydney, Australia, and brings a global perspective and execution-focused leadership approach to advancing innovative therapies.

Sarah Stoll

Regional VP, West

Sarah Stoll

Regional VP, West

Sarah Stoll serves as Regional Vice President for the West region at Project Farma, where she leads delivery and operational strategy across pharmaceutical, biotechnology, and gene therapy programs. In this role, Sarah oversees complex capital initiatives and partners closely with clients to drive execution across highly regulated environments.

Sarah brings more than 10 years of experience in capital project delivery, operational strategy, and program execution, with expertise spanning the full project lifecycle, from project initiation and funding requests through design, construction, commissioning and qualification, validation, and closeout. She is experienced in leading cross-functional teams and managing complex, multi-stakeholder programs that require tight alignment across technical, operational, and governance functions.

A proven leader, Sarah is known for building high-performing teams and delivering strategic outcomes in fast-paced environments. She brings a hands-on, execution-focused approach to complex challenges, providing clear direction and technical oversight from conceptual design through final delivery, while ensuring alignment with client priorities at every phase.

Christian Hermanas

Market Director,
Research Triangle Park

Christian Hermanas

Market Director,
Research Triangle Park

Christian Hermanas serves as Market Director for the Research Triangle Park (RTP), North Carolina market at Project Farma, where he supports delivery and growth across biotechnology and advanced therapy programs. In this role, Christian partners with clients to drive execution across complex, regulated manufacturing environments.

Christian is a biotechnology veteran with a background in project engineering and project management. He has supported multiple gene therapy manufacturing facility design and build programs valued up to $400MM, and has worked with pre-clinical and clinical organizations to characterize manufacturing processes and prepare for commercialization scale-up.

Christian holds a degree in Biochemical Engineering from the University of Southern California and brings deep technical insight and hands-on execution experience to supporting innovative therapies from early development through commercial readiness.

Dan Lewis

Market Director, Indianapolis

Dan Lewis

Market Director, Indianapolis

Dan Lewis serves as Market Director for the Indianapolis, Indiana market at Project Farma, where he leads market development and client engagement across the life sciences and advanced manufacturing sectors. In this role, Dan partners closely with clients to drive growth initiatives, support site builds and expansions, and align Project Farma’s technical capabilities with client needs.

Dan brings more than 16 years of commercial leadership experience, with a proven track record of driving revenue growth, securing new site builds, and partnering with C-suite leaders at top 25 pharmaceutical and biotechnology organizations. He has originated more than $100MM in consulting and technical operations engagements and has led sales and marketing organizations of 20–30+ professionals across highly regulated industries.

His experience includes supporting capital expansion, automation, validation, and digital transformation programs across major pharmaceutical manufacturing facilities. In addition to his consulting leadership background, Dan founded an AI-driven business strategy startup and brings strong expertise in leveraging AI-enabled targeting and analytics to accelerate market growth and inform go-to-market strategy.

Evan Bryant

Market Director, DC, Maryland & Virginia

Evan Bryant

Market Director, DC, Maryland & Virginia

Evan Bryant is a Market Director for the DC, Maryland, and Virginia (DMV) market at Project Farma, where he supports clients across regulated manufacturing environments through hands-on technical leadership and execution support. In this role, Evan partners closely with production and engineering teams to drive operational performance and project delivery.

Evan brings several years of experience supporting the start-up of high-volume cell therapy manufacturing operations, consistently meeting Patient Readiness targets while advancing safety, quality, and process control objectives. He has a strong track record of providing hands-on technical support to production teams and driving continuous process improvement within regulated environments.

His background includes extensive experience in GMP manufacturing, operational readiness, and Capital Project Management. Evan has also supported capital renovation projects involving equipment and utility system specification, procurement, testing, qualification, vendor management, and the oversight of preventative and corrective maintenance programs. He holds a Bachelor of Science in Mechanical Engineering from Michigan State University.

Joe Kenar

Market Director, Chicago

Joe Kenar

Market Director, Chicago

Joe Kenar serves as Market Director for the Chicago market at Project Farma, where he supports clients through technical manufacturing solutions, operational readiness, and validation-driven program delivery. In this role, Joe partners with clients to execute complex programs across regulated manufacturing environments.

Joe has been a cornerstone of Project Farma for more than five years, progressing through roles of increasing responsibility and contributing to a wide range of client engagements across markets. He is recognized for his leadership, technical aptitude, and strong commitment to Project Farma’s culture and client success.

His background spans engineering, commissioning and qualification, and program management, with hands-on experience supporting major aseptic filling line projects, utility qualifications, instrumentation initiatives, and large-scale facility expansions. Joe brings an execution-focused approach to delivering high-quality outcomes in highly regulated environments.

Chris Riddick

Market Director, New Jersey

Chris Riddick

Market Director, New Jersey

Chris Riddick serves as Market Director for the New Jersey market at Project Farma, where he partners with pharmaceutical and biotechnology organizations to support the development, regulatory approval, and commercial supply of life-saving therapies. In this role, Chris focuses on aligning technical execution with client objectives across highly regulated environments.

Chris brings more than a decade of experience supporting organizations across the full drug development lifecycle, from early discovery through commercial release. His background includes managing capital projects for multinational Fortune 100 pharmaceutical companies, supporting lean transformations within biotech startups and CMOs, and leading operations and engineering teams through complex technology transfers.

He is recognized as a trusted partner for his ability to engage with clients at every stage of the pipeline, bringing practical, execution-focused leadership to complex operational and manufacturing challenges across the life sciences industry.

Vaness Harris

Market Director, Los Angeles

Vaness Harris

Market Director, Los Angeles

Vaness Harris serves as Market Director for the Los Angeles, Thousand Oaks, and Glendale, California markets at Project Farma, where he supports pharmaceutical, biotechnology, and medical device organizations across complex, regulated environments. In this role, Vaness partners with clients to drive execution across validation, regulatory compliance, and large-scale capital programs.

Vaness brings more than 20 years of technical leadership and regulatory expertise, with deep specialization in commissioning, qualification, and validation (CQV), regulatory compliance, and capital project execution. His experience includes leading complex CQV initiatives, supporting IND, NDA, and BLA submissions, and providing subject matter expertise across GMP, GLP, and GCP compliance, FDA inspection readiness, aseptic manufacturing, and CMC regulatory strategy.

He holds a Bachelor of Science in General Biology from the University of California, San Diego, with an academic focus on biological, chemical, and environmental sciences, and is recognized for his hands-on, execution-focused approach to advancing compliant, high-performing manufacturing operations.